Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13774872 | 0.75 | GAA (0.46) | TSHR | |
| SCHEMBL8569867 | 0.73 | ELANE (0.38) | MGLLACHETSHR | |
| SCHEMBL2529389 | 0.70 | MMP1 (0.42) | MGLLTSHR | |
| SCHEMBL18730849 | 0.70 | TSHR (0.38) | MGLLACHETSHR | |
| Phosphonic Acid SCHEMBL28543973 | 0.69 | MGLL (0.47) | MGLLACHETSHR | |
| SCHEMBL5068929 | 0.69 | MGLL (0.34) | MGLLACHETSHR | |
| SCHEMBL2506945 | 0.69 | ALDH1A1 (0.33) | TSHR | |
| SCHEMBL6100238 | 0.69 | ADRA2A (0.37) | MGLLACHETSHR | |
| Ammonia Solution, Strong SCHEMBL497430 | 0.69 | MMP1 (0.41) | MGLLTSHR | |
| SCHEMBL1039111 | 0.69 | ADRA2A (0.37) | MGLLACHETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7485745-B2 | Mixtures composed of monocarboxy-functionalized dialkylphosphinic esters and of further components | CLARIANT INTERNATIONAL LTD. (CH) | 2009-02-03 | — | — | US | disclosed |
| US-20070210288-A1 | Mixtures composed of monocarboxy-functionalized dialkylphosphinic esters and of further components | CLARIANT INTERNATIONAL LTD | 2007-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070210288-A1 | Mixtures composed of monocarboxy-functionalized dialkylphosphinic esters and of further components | ALKBH3, FFAR3, EBP | MGLL 95/4885ACHE 4792/4885TSHR 1202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.